Table 1.
Characteristics of cancer survivors and participants without cancer at the 2016 wave of the health and retirement study
| Variables | Cancer survivors n = 1454 (16.4%) | Participants without cancer n = 7429 (83.6%) | p-value |
|---|---|---|---|
|
| |||
| Mean ± SEM/ N (%) | Mean ± SEM/ N (%) | ||
| Age (years) | 72 ± 0.5 | 67.9 ± 0.2 | < 0.0001 |
| Sex (%Female) | 780 (53.6%) | 4017 (54.1%) | 0.83 |
| Race | |||
| Hispanics | 80 (5.5%) | 733 (9.9%) | < 0.0001 |
| Non hispanic whites | 1213 (83.4%) | 5709 (76.8%) | |
| Non hispanic blacks | 131 (9.0%) | 733 (9.9%) | |
| Other | 30 (2.1%) | 254 (3.4%) | |
| Years of education | 13.7 ± 0.1 | 13.6 ± 0.1 | 0.6 |
| Comorbidity | 2.4 ± 0.1 | 2.0 ± 0.02 | < 0.0001 |
| CMV seropositivity (% Reactive) | 923 (63.4%) | 4707 (63.4%) | 0.97 |
| C-Reactive protein (High Sensitivity) mg/L* | 6 ± 0.7 | 4.4 ± 0.1 | < 0.0001 |
| Neutrophil-to-Lymphocyte ratio* | 2.6 ± 0.1 | 2.2 ± 0.02 | < 0.0001 |
| Inflammation score (% High) | 56 (3.9%) | 205 (2.8%) | 0.02 |
| Cognitive scores | 15.3 ± 0.2 | 15.7 ± 0.1 | 0.02 |
| Cognitive status | 0.14 | ||
| Normal | 1176 (80.9%) | 6193 (83.4%) | |
| CIND | 223 (15.3%) | 1012 (13.6%) | |
| Dementia | 55 (3.8%) | 224 (3.0%) | |
| Cognitive impairment (%Yes) | 278 (19.1%) | 1236 (16.6%) | 0.08 |
*
These variables were logarithmically transformed to approximate a normal distribution in the regression model
SEM Standard Error of Mean, CIND Cognitive Impairment Not Dementia, CMV Cytomegalovirus
The models were adjusted for survey design parameters (strata and cluster for sampling error and participant sample weights for the 2016 HRS Venous Blood Study)